NEWS

This article reviews and summarizes the latest regulatory developments in China's cosmetics sector during the first half of 2025. It covers updates in laws and regulations, ministerial rules, technical standards, and other relevant aspects. The aim is to help enterprises stay informed of policy changes, ensure compliant product launches, and effectively enhance market competitiveness.

In July 2025, the provincial Medical Products Administrations (MPAs) of Gansu, Guangdong, and Jiangxi successively issued public notices regarding the results of cosmetic product sampling inspections, with a total of six batches found to be non-compliant with relevant regulations. This article provides a summary and analysis of the key points from these announcements, and also reviews recent developments in cosmetic sampling inspections and special regulatory campaigns carried out in various provinces and cities. The aim is to help enterprises stay informed of regulatory trends, and to strengthen their awareness of quality management and regulatory compliance.

Based on data retrieved from China’s National Medical Products Administration (NMPA), six new cosmetic ingredients have successfully been filed between August 1 and August 11, 2025. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period.

On July 16, 2025, the European Union (EU) submitted notification G/TBT/N/EU/1148 to the World Trade Organization (WTO), aiming at simplification of the certain provisions and procedures of the following acts: Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (“CLP Regulation”); Regulation (EC) No 1223/2009 on cosmetic products (“the Cosmetic Products Regulation”); and Regulation (EU) 2019/1009 laying down rules on the making available on the market of EU fertilising products (“Fertilising Products Regulation”)

This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of July 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

In China, when conducting risk assessments for cosmetics, all components must be evaluated. Typically, for impurities present at very low levels that lack toxicological data, the Threshold of Toxicological Concern (TTC) method can be used for assessment.

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS), under Mexico’s Ministry of Health (Secretaría de Salud), is responsible for regulating the market authorization, compliance review, and post-market surveillance of products such as cosmetics, pharmaceuticals, medical devices, food, and dietary supplements. With regard to cosmetics, COFEPRIS oversees the entire lifecycle of products-including manufacturing, importation, distribution, and commercialization-to ensure that all products placed on the market meet established safety standards.

On July 10, 2025, the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia issued Announcement No. Bil (18) dlm. NPRA/PPPK/01/04 to revise the Cosmetic Regulatory Guidelines in Malaysia. The updated guidelines take effect from the date of publication.

On July 10, 2025, the Ministry of Food and Drug Safety (MFDS) of South Korea announced the latest revision to the Enforcement Rules of the Cosmetics Act (Prime Ministerial Decree No. 1970). The amendment introduces systematic adjustments in key areas, including functional cosmetics, customized cosmetics, and cosmetics for infants and young children.

On 30 June, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1679/25) on Benzophenone-2 (BP-2)(CAS No. 131-55-5, EC No. 205-028-9) and Benzophenone-5 (BP-5) (CAS No. 6628-37-1, EC No. 613-918-7).